Blossoming Biotech: Turning Point Seeds Grow $100M to Challenge Traditional Drugs
TLDR: BlossomHill Therapeutics, a new biotech company founded by J. Jean Cui, Ph.D., has raised $100 million in series B financing. The company aims to develop small molecule drugs for high-need cancers